• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[脂肪性水肿:一种误诊的病症]

[Lipedema: a misdiagnosed entity].

作者信息

Vignes S

机构信息

Unité de lymphologie, centre national de référence des maladies vasculaires rares (lymphœdèmes primaires), hôpital Cognacq-Jay, 15, rue Eugène-Millon, 75015 Paris, France.

出版信息

J Mal Vasc. 2012 Jul;37(4):213-8. doi: 10.1016/j.jmv.2012.05.002. Epub 2012 Jun 13.

DOI:10.1016/j.jmv.2012.05.002
PMID:22698628
Abstract

Lipedema is a clinical entity frequently misdiagnosed or confound with primary lymphedema. Lipedema is a disorder of adipose tissue that occurs almost exclusively in obese women. It is characterized by bilateral enlargement from hip to ankle due to abnormal depositions of subcutaneous fat associated with often mild edema, usually sparing the feet. Disease onset is usually at or soon after puberty. Lipedema results in considerable frustration and distress resulting from the cosmetic appearance. Patients may complain of pain, tenderness, easy bruising of the affected areas with moderate to severe sensitivity to digital pressure or pinching. Imaging studies using computed tomography, magnetic resonance imaging, ultrasound, lymphoscintigraphy are not indicated, except if the diagnosis is atypic or doubtful. Long-term evolution may alter lymphatic system and lead to a lipo-lymphedema with specific complications such as cellulitis. Lipedema management is not codified and included weight loss (poorly improving leg appearance or discomfort), psychological counselling and compression therapy. Liposuction, especially using tumescent local anaesthesia, may reduce edema, spontaneous pain, sensitivity to pressure, bruising and improve appearance resulting in a important increase in quality of life.

摘要

脂肪性水肿是一种常被误诊或与原发性淋巴水肿混淆的临床病症。脂肪性水肿是一种几乎仅发生于肥胖女性的脂肪组织疾病。其特征是从臀部到脚踝双侧肿大,这是由于皮下脂肪异常沉积并伴有轻度水肿所致,通常不累及足部。发病通常在青春期或青春期后不久。脂肪性水肿会因外观问题导致相当大的沮丧和痛苦。患者可能会抱怨受影响区域疼痛、压痛、容易瘀青,对指压或捏掐有中度至重度敏感。除诊断不典型或存疑外,不建议使用计算机断层扫描、磁共振成像、超声、淋巴闪烁造影等影像学检查。长期发展可能会改变淋巴系统并导致脂肪性淋巴水肿及蜂窝织炎等特定并发症。脂肪性水肿的治疗方法尚无规范,包括减肥(对改善腿部外观或不适效果不佳)、心理咨询和压迫疗法。抽脂术,尤其是使用肿胀局麻,可减轻水肿、自发疼痛、对压力的敏感度、瘀青,并改善外观,从而显著提高生活质量。

相似文献

1
[Lipedema: a misdiagnosed entity].[脂肪性水肿:一种误诊的病症]
J Mal Vasc. 2012 Jul;37(4):213-8. doi: 10.1016/j.jmv.2012.05.002. Epub 2012 Jun 13.
2
Lipedema, a frequently unrecognized problem.脂肪性水肿,一个常常未被认识到的问题。
J Am Acad Dermatol. 2007 Aug;57(2 Suppl):S1-3. doi: 10.1016/j.jaad.2006.09.023.
3
Long-term Outcome After Surgical Treatment of Lipedema.脂肪性水肿手术治疗后的长期结果
Ann Plast Surg. 2012 Mar;68(3):303-7. doi: 10.1097/SAP.0b013e318215791e.
4
Lipedema: a frequently misdiagnosed and misunderstood fatty deposition syndrome.脂肪代谢障碍:一种常被误诊和误解的脂肪沉积综合征。
Adv Skin Wound Care. 2010 Feb;23(2):81-92; quiz 93-4. doi: 10.1097/01.ASW.0000363503.92360.91.
5
[Lipedema, a barely known disease: diagnosis, associated diseases and therapy].[脂肪性水肿,一种鲜为人知的疾病:诊断、相关疾病及治疗]
Orv Hetil. 2008 Nov 9;149(45):2121-7. doi: 10.1556/OH.2008.28490.
6
7
Lipedema: an inherited condition.脂肪营养不良症:一种遗传性疾病。
Am J Med Genet A. 2010 Apr;152A(4):970-6. doi: 10.1002/ajmg.a.33313.
8
Thick legs - not always lipedema.腿部粗壮 - 不一定是脂肪水肿。
J Dtsch Dermatol Ges. 2013 Mar;11(3):225-33. doi: 10.1111/ddg.12024. Epub 2012 Dec 11.
9
Lipedema-An update.脂肪水肿——最新进展。
Dermatol Ther. 2019 Mar;32(2):e12805. doi: 10.1111/dth.12805. Epub 2018 Dec 27.
10
Lymphedema treatment decreases pain intensity in lipedema.脂肪水肿的淋巴水肿治疗可降低疼痛强度。
Lymphology. 2011 Dec;44(4):178-82.

引用本文的文献

1
Lymphoscintigraphic alterations in lower limbs in women with lipedema in comparison to women with overweight/obesity.与超重/肥胖女性相比,脂肪性水肿女性下肢的淋巴闪烁造影改变。
Front Physiol. 2023 Apr 10;14:1099555. doi: 10.3389/fphys.2023.1099555. eCollection 2023.